2089377-85-3 Usage
Uses
Used in Organic Synthesis:
(6-(methylsulfonyl)pyridin-3-yl)methanol is utilized as a key building block in organic synthesis, particularly for the creation of various pharmaceutical compounds. Its unique structure allows for the development of novel molecules with potential therapeutic properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (6-(methylsulfonyl)pyridin-3-yl)methanol serves as an important intermediate for the synthesis of pharmaceuticals. Its structural features enable the design and synthesis of new drugs with improved efficacy and selectivity.
Used in Pharmaceutical Development:
(6-(methylsulfonyl)pyridin-3-yl)methanol holds promise for pharmaceutical development due to its potential biological activities and therapeutic applications. Although further research is necessary to fully understand its pharmacological properties, its unique chemical structure suggests it may play a role in the development of new treatments for various diseases.
Used in Research and Development:
(6-(methylsulfonyl)pyridin-3-yl)methanol is also valuable in research and development settings, where it can be used to explore new chemical reactions and investigate the properties of related compounds. Its potential applications in drug discovery and the development of novel materials make it a valuable tool for scientists and researchers in the field.
Check Digit Verification of cas no
The CAS Registry Mumber 2089377-85-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,0,8,9,3,7 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2089377-85:
(9*2)+(8*0)+(7*8)+(6*9)+(5*3)+(4*7)+(3*7)+(2*8)+(1*5)=213
213 % 10 = 3
So 2089377-85-3 is a valid CAS Registry Number.
2089377-85-3Relevant academic research and scientific papers
Heterocyclic phosphodiesterase inhibitor and uses thereof
-
Paragraph 0133-0137, (2019/11/04)
The present invention belongs to the technical field of medicine, and particularly relates to a heterocyclic phosphodiesterase inhibitor compound represented by a formula (I), or a pharmaceutically acceptable salt and a stereoisomer thereof, and a pharmaceutical preparation, a pharmaceutical composition and applications of the compound, wherein R1, R2, R3, R4, ring A, m and n are defined in the specification. According to the present invention, the compound can be used for preparing drugs for treatment or prevention of diseases associated with PDE9 kinase.
HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
-
Paragraph 0293, (2018/09/20)
The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as i
